The first prognostic model for stroke and death in patients with systolic heart failure.
CONCLUSIONS: This novel prognostic model predicts the overall risk of ischemic stroke or death for HF patients. This model compares favorably for death with the Seattle model and has the added utility of including stroke as an endpoint. Use of this model will help identify those patients in need of more intensive monitoring and therapy and may help identify appropriate populations for trials of new therapies.
CLINICAL TRIAL REGISTRATION: http://www.Clinicatrials.govNCT00041938.
PMID: 26549533 [PubMed - as supplied by publisher]
Source: Journal of Cardiology - Category: Cardiology Authors: Freudenberger RS, Cheng B, Mann DL, Thompson JL, Sacco RL, Buchsbaum R, Sanford A, Pullicino PM, Levin B, Teerlink JR, Graham S, Mohr JP, Labovitz AJ, Di Tullio MR, Lip GY, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Homma S, WARCEF Investigators Tags: J Cardiol Source Type: research
More News: Aspirin | Cardiology | Clinical Trials | Coumadin | Diabetes | Endocrinology | Heart | Heart Failure | Ischemic Stroke | Stroke | Study | Warfarin